Hostname: page-component-848d4c4894-nmvwc Total loading time: 0 Render date: 2024-06-15T17:02:01.771Z Has data issue: false hasContentIssue false
  • English
  • Français

Hepatitis B and Hemodialysis: The Impact of Universal Precautions in Preventing the Transmission of Bloodborne Viruses

Published online by Cambridge University Press:  02 January 2015

Aloys C.M. Kroes ,
Eric F.H. van Bommel ,
Jan A.J.W. Kluytmans  and
Willem Weimar
Aloys C.M. Kroes*
Affiliation:
Department of Virology, University Hospital Dijkzigt, Rotterdam, The Netherlands
Eric F.H. van Bommel
Affiliation:
Department of Internal Medicine I, Division of Nephrology, University Hospital Dijkzigt, Rotterdam, The Netherlands
Jan A.J.W. Kluytmans
Affiliation:
Department of Medical Microbiology, University Hospital Dijkzigt, Rotterdam, The Netherlands
Willem Weimar
Affiliation:
Department of Internal Medicine I, Division of Nephrology, University Hospital Dijkzigt, Rotterdam, The Netherlands
*
Department of Virology, E4-P, Leiden University Hospital, P.O. Box 9600, 2300 RC Leiden, The Netherlands; e-mail, kroes@virology.azl.nl
Get access Rights & Permissions [Opens in a new window]

Abstract

A detailed description is presented of the hemodialysis treatment for 6 weeks of a patient strongly positive for hepatitis B virus ([HBV], hepatitis B surface antigen, hepatitis B e antigen, HBV DNA), which was performed without any special precautions. All 59 patients potentially exposed to the HBV-positive patient, of whom 29 appeared fully unprotected by antibody, were followed for at least 9 months but remained negative. This illustrates the feasibility of following Universal Precautions instead of using exceptional procedures for one single agent

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 19 , Issue 7 , July 1998 , pp. 508 - 510
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Garibaldi, RA, Forrest, JN, Bryan, JA, Hanson, BF, Dismukes, WE. Hemodialysis-associated hepatitis. JAMA 1973;225:384–389.CrossRefGoogle ScholarPubMed
2. Alter, MJ, Favero, MS, Maynard, JE. Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States. J Infect Dis 1986;153:1149–1151.CrossRefGoogle ScholarPubMed
3. Maggiore, Q, Catalano, C. Viral hepatitis in dialysis units: a changing scenario. Contrib Nephrol 1988;61:240–253.CrossRefGoogle ScholarPubMed
4. Velandia, M, Fridkin, SK, Cardenas, V, Boshell, J, Ramirez, G, Bland, L, et al. Transmission of HIV in dialysis centre. Lancet 1995;345:1417–1422.Google Scholar
5. Sampietro, M, Badalamenti, S, Graziani, G. Nosocomial hepatitis C in dialysis units. Nephron 1996;74:251–260.CrossRefGoogle ScholarPubMed
6. Masuko, K, Mitsui, T, Iwano, K, Yamazaki, C, Okuda, K, Meguro, T, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996;334:1485–1490.Google Scholar
7. Dueymes, JM, Bodenes-Dueymes, JL, Mahé, JL, Herman, B. Detection of hepatitis B viral DNA by polymerase chain reaction in dialysis patients. Kidney Int 1993;43:S161–S166.Google Scholar
8. Carl, M, Francis, DP, Maynard, JE. A common-source outbreak of hepatitis B in a hemodialysis unit. Dialysis and Transplantation 1983;12:222–229.Google Scholar
9. Centers for Disease Control and Prevention. Outbreaks of hepatitis B virus infection among hemodialysis patients–California, Nebraska, and Texas, 1994. MMWR 1996;45:285–289.Google Scholar
10. Seme, K, Poljak, M, Zuzek-Resek, S, Debeljak, M, Dovc, P, Koren, S. Molecular evidence for nosocomial spread of two different hepatitis C virus strains in one hemodialysis unit. Nephron 1997;77:273–278.CrossRefGoogle ScholarPubMed